Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
SESSION 4: TRIPLE NEGATIVE BREAST CANCER
Immunotherapy: Where We Are, Where Are We Going?
Thursday, April 28, 2022
9:05 AM – 9:25 AM
Speaker(s)
Javier Cortes, MD, PhD
International Breast Cancer Center
Barcelona
Learning Objectives:
Evaluate the mechanisms, safety, and efficacy data of newer and emerging agents in the treatment of TNBC
Discuss monitoring and managing treatment-related adverse effects in the setting of TNBC